🇨🇭·4h agoIndustry
3 Fragen an unser neues Boardmitglied: Michele Ravara, General Manager AbbVie Switzerland
Publisher
I
Interpharma Switzerland
Switzerland
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Interpharma Switzerland
- Region
- Switzerland
- Scope
- Industry
- Published
- June 25, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on interpharma.ch
Leave the platform to read the original full article on the publisher site.
Source: Interpharma Switzerland
Scope: Industry
Related coverage
More related coverage
Certara/4h ago
How to Build a Best Practice Global Value Dossier With a Decision-first Strategy
Merck & Co. (MSD) News/9h ago
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)
Eli Lilly News/9h ago
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
Eledon Pharmaceuticals/3h ago